BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27425885)

  • 41. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
    Lee JC; Shin JH; Park BW; Kim GS; Kim JC; Kang KS; Cha CI
    Brain Res; 2012 Jan; 1433():20-8. PubMed ID: 22137654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
    Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
    Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice.
    Just-Borràs L; Hurtado E; Cilleros-Mañé V; Biondi O; Charbonnier F; Tomàs M; Garcia N; Lanuza MA; Tomàs J
    Mol Neurobiol; 2019 Oct; 56(10):6856-6872. PubMed ID: 30929165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.
    Nichols NL; Satriotomo I; Harrigan DJ; Mitchell GS
    Exp Neurol; 2015 Nov; 273():138-50. PubMed ID: 26287750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Region-specific changes in the immunoreactivity of TRPV4 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
    Lee JC; Joo KM; Choe SY; Cha CI
    J Mol Histol; 2012 Dec; 43(6):625-31. PubMed ID: 22714109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis.
    Zhang X; Chen S; Li L; Wang Q; Le W
    J Neurol Sci; 2010 Jun; 293(1-2):102-5. PubMed ID: 20334883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression.
    Pullen AH; Athanasiou D
    Eur J Neurosci; 2009 Feb; 29(3):551-61. PubMed ID: 19187267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice.
    Bonfanti E; Bonifacino T; Raffaele S; Milanese M; Morgante E; Bonanno G; Abbracchio MP; Fumagalli M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies.
    Brancia C; Noli B; Boido M; Boi A; Puddu R; Borghero G; Marrosu F; Bongioanni P; Orrù S; Manconi B; D'Amato F; Messana I; Vincenzoni F; Vercelli A; Ferri GL; Cocco C
    PLoS One; 2016; 11(10):e0164689. PubMed ID: 27737014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.